Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Dengue control in Pakistan: prior planning is better than controlling too late.
Hussain M, Majeed A, Imran I, Rasool MF, Hussain I, Ghaffar A, Wu X.
BMJ. 2019 Dec 12;367:l6912. doi: 10.1136/bmj.l6912. No abstract available.
Similar articles
Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations.
Rasool MF, Khalid S, Majeed A, Saeed H, Imran I, Mohany M, Al-Rejaie SS, Alqahtani F.
Pharmaceutics. 2019 Nov 5;11(11). pii: E578. doi: 10.3390/pharmaceutics11110578.
Pharmacological Studies Pertaining to Smooth Muscle Relaxant, Platelet Aggregation Inhibitory and Hypotensive Effects of Ailanthus altissima.
Rahman HMA, Rasool MF, Imran I.
Evid Based Complement Alternat Med. 2019 Mar 3;2019:1871696. doi: 10.1155/2019/1871696. eCollection 2019.
Pharmacological evaluation of smooth muscle relaxant and cardiac-modulation potential of Phyla nodiflora in ex-vivo and in-vivo experiments.
Abdur Rahman HM, Ahmed K, Rasool MF, Imran I.
Asian Pac J Trop Med. 2017 Dec;10(12):1146-1153. doi: 10.1016/j.apjtm.2017.10.021. Epub 2017 Oct 31.
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.
Rasool MF, Khalil F, Läer S.
Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):383-396. doi: 10.1007/s13318-016-0353-2.
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach.
Drug Metab Dispos. 2016 Jul;44(7):1103-15. doi: 10.1124/dmd.115.068858. Epub 2016 Apr 11.
Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows.
Clin Pharmacokinet. 2016 Jan;55(1):139-41. doi: 10.1007/s40262-015-0349-0. No abstract available.
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
Clin Pharmacokinet. 2015 Sep;54(9):943-62. doi: 10.1007/s40262-015-0253-7.
Filters: Manage Filters